AI assistant
Sending…
MetaVia Inc. — Director's Dealing 2019
Dec 31, 2019
34919_dirs_2019-12-30_c7bb44c2-fafd-4009-93b7-141e4952f408.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Gemphire Therapeutics Inc. (NRBO)
CIK: 0001638287
Period of Report: 2019-12-30
Reporting Person: Jeong Tae Heum (Director)
More from MetaVia Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Apr 3